Marc Antoine Jean Juste, Yvetot Joseph, Dominique Lespinasse, Alexandra Apollon, Parmida Jamshidi, Myung Hee Lee, Maureen Ward, Esther Brill, Yanique Duffus, Uche Chukwukere, Ali Danesh, Winiffer Conce Alberto, Daniel W Fitzgerald, Jean W Pape, R Brad Jones, Kathryn Dupnik
{"title":"People Living With HIV Have More Intact HIV DNA in Circulating CD4+ T Cells if They Have History of Pulmonary Tuberculosis.","authors":"Marc Antoine Jean Juste, Yvetot Joseph, Dominique Lespinasse, Alexandra Apollon, Parmida Jamshidi, Myung Hee Lee, Maureen Ward, Esther Brill, Yanique Duffus, Uche Chukwukere, Ali Danesh, Winiffer Conce Alberto, Daniel W Fitzgerald, Jean W Pape, R Brad Jones, Kathryn Dupnik","doi":"10.20411/pai.v9i2.722","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A primary barrier to curing HIV is the HIV reservoir. The leading infectious cause of death worldwide for people living with HIV is tuberculosis (TB), but we do not know how TB impacts the HIV reservoir.</p><p><strong>Methods: </strong>Participants in identification and validation cohorts were selected from previously enrolled studies at Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) in Port au Prince, Haiti. Intact and non-intact proviral DNA were quantified using droplet digital PCR of peripheral blood mononuclear cell (PBMC)-derived CD4+ T cells. Kruskal-Wallis tests were used to compare medians with tobit regression for censoring.</p><p><strong>Results: </strong>In the identification cohort, we found that people living with HIV with a history of active pulmonary TB (n=19) had higher levels of intact provirus than people living with HIV without a history of active TB (n=47) (median 762; IQR, 183-1173 vs 117; IQR, 24-279 intact provirus per million CD4, respectively; <i>P</i>=0.0001). This difference also was seen in the validation cohort (n=31), (median 102; IQR, 0-737 vs 0; IQR, 0-24.5 intact provirus per million CD4, <i>P</i>=0.03) for TB vs no-TB history groups, respectively. The frequencies of CD4+ T cells with any detectable proviral fragment was directly proportional to the levels of interleukin-1 beta (r=0.524, <i>P</i>= 0.0025) and interleukin-2 (r=0.622, <i>P</i>=0.0002).</p><p><strong>Conclusions: </strong>People living with HIV with a history of active pulmonary TB have more HIV pro-virus in their circulating CD4+ T cells, even years after TB cure. We need to characterize which CD4+ T cells are harboring intact provirus to consider the impact of T cell-targeting HIV cure interventions for people living in TB-endemic areas.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"9 2","pages":"172-193"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11432494/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathogens and Immunity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20411/pai.v9i2.722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: A primary barrier to curing HIV is the HIV reservoir. The leading infectious cause of death worldwide for people living with HIV is tuberculosis (TB), but we do not know how TB impacts the HIV reservoir.
Methods: Participants in identification and validation cohorts were selected from previously enrolled studies at Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) in Port au Prince, Haiti. Intact and non-intact proviral DNA were quantified using droplet digital PCR of peripheral blood mononuclear cell (PBMC)-derived CD4+ T cells. Kruskal-Wallis tests were used to compare medians with tobit regression for censoring.
Results: In the identification cohort, we found that people living with HIV with a history of active pulmonary TB (n=19) had higher levels of intact provirus than people living with HIV without a history of active TB (n=47) (median 762; IQR, 183-1173 vs 117; IQR, 24-279 intact provirus per million CD4, respectively; P=0.0001). This difference also was seen in the validation cohort (n=31), (median 102; IQR, 0-737 vs 0; IQR, 0-24.5 intact provirus per million CD4, P=0.03) for TB vs no-TB history groups, respectively. The frequencies of CD4+ T cells with any detectable proviral fragment was directly proportional to the levels of interleukin-1 beta (r=0.524, P= 0.0025) and interleukin-2 (r=0.622, P=0.0002).
Conclusions: People living with HIV with a history of active pulmonary TB have more HIV pro-virus in their circulating CD4+ T cells, even years after TB cure. We need to characterize which CD4+ T cells are harboring intact provirus to consider the impact of T cell-targeting HIV cure interventions for people living in TB-endemic areas.
背景:艾滋病病毒库是治愈艾滋病的主要障碍。结核病是导致全球艾滋病病毒感染者死亡的主要传染病,但我们并不知道结核病如何影响艾滋病病毒库:方法:从海地太子港的 Grouïtien d'Étude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) 先前登记的研究中挑选识别和验证队列的参与者。使用外周血单核细胞(PBMC)衍生的 CD4+ T 细胞的液滴数字 PCR 对完整和非完整的前病毒 DNA 进行了定量。采用 Kruskal-Wallis 检验比较中位数,并用 tobit 回归进行普查:在鉴定队列中,我们发现有活动性肺结核病史的 HIV 感染者(19 人)比无活动性肺结核病史的 HIV 感染者(47 人)有更高水平的完整病毒(中位数分别为 762;IQR,183-1173 vs 117;IQR,每百万 CD4 24-279 个完整病毒;P=0.0001)。在验证队列(n=31)中,结核病史组与无结核病史组也分别出现了这种差异(中位数 102;IQR,0-737 vs 0;IQR,0-24.5)。可检测到任何前病毒片段的 CD4+ T 细胞的频率与白细胞介素-1 beta(r=0.524,P= 0.0025)和白细胞介素-2(r=0.622,P=0.0002)的水平成正比:结论:有活动性肺结核病史的艾滋病病毒感染者的循环 CD4+ T 细胞中含有更多的艾滋病原病毒,即使在结核病治愈多年后也是如此。我们需要确定哪些 CD4+ T 细胞携带完整的原病毒,以考虑针对 T 细胞的 HIV 治愈干预措施对结核病流行地区患者的影响。